| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.0087 | 1 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |